168 related articles for article (PubMed ID: 38123759)
1. Water and Electrolyte Content in Salt-Dependent HYpertension in the SKIn (WHYSKI): Effect of Surgical Cure of Primary Aldosteronism.
Torresan F; Rossi FB; Zanin S; Caputo I; Caroccia B; Iacobone M; Rossi GP
High Blood Press Cardiovasc Prev; 2024 Jan; 31(1):15-21. PubMed ID: 38123759
[TBL] [Abstract][Full Text] [Related]
2. Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake.
Adolf C; Heinrich DA; Holler F; Lechner B; Nirschl N; Sturm L; Görge V; Riester A; Williams TA; Treitl M; Ladurner R; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2020 Mar; 105(3):e484-93. PubMed ID: 31702016
[TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism: Practical recommendations for treatment and follow-up.
Araujo-Castro M; Pascual-Corrales E; Martín Rojas P; Parra Ramírez P
Hipertens Riesgo Vasc; 2023; 40(4):215-221. PubMed ID: 37993292
[TBL] [Abstract][Full Text] [Related]
6. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
[TBL] [Abstract][Full Text] [Related]
7. Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.
Rossitto G; Cesari M; Ceolotto G; Maiolino G; Seccia TM; Rossi GP
J Hum Hypertens; 2019 Feb; 33(2):167-171. PubMed ID: 30518805
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism.
Lim V; Guo Q; Grant CS; Thompson GB; Richards ML; Farley DR; Young WF
J Clin Endocrinol Metab; 2014 Aug; 99(8):2712-9. PubMed ID: 24796926
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of drug-based and surgical treatments for primary aldosteronism.
Steichen O; Lorthioir A; Zinzindohoue F; Plouin PF; Amar L
Adv Chronic Kidney Dis; 2015 May; 22(3):196-203. PubMed ID: 25908468
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.
Amar L; Plouin PF; Steichen O
Orphanet J Rare Dis; 2010 May; 5():9. PubMed ID: 20482833
[TBL] [Abstract][Full Text] [Related]
11. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
Tezuka Y; Turcu AF
Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
[TBL] [Abstract][Full Text] [Related]
12. KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission After Adrenalectomy for Unilateral Primary Aldosteronism.
Vilela LAP; Rassi-Cruz M; Guimaraes AG; Moises CCS; Freitas TC; Alencar NP; Petenuci J; Goldbaum TS; Maciel AAW; Pereira MAA; Silva GV; Pio-Abreu A; Zerbini MCN; Cavalcante ACBS; Carnevale FC; Pilan B; Yamauchi F; Srougi V; Tanno FY; Chambo JL; Latronico AC; Mendonca BB; Fragoso MCBV; Bortolotto LA; Drager LF; Almeida MQ
J Clin Endocrinol Metab; 2019 Oct; 104(10):4695-4702. PubMed ID: 31216002
[TBL] [Abstract][Full Text] [Related]
13. Outcome of surgical treatment of primary aldosteronism.
Citton M; Viel G; Rossi GP; Mantero F; Nitti D; Iacobone M
Langenbecks Arch Surg; 2015 Apr; 400(3):325-31. PubMed ID: 25567077
[TBL] [Abstract][Full Text] [Related]
14. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the diagnosis and treatment of primary aldosteronism.
Yoshida Y; Shibata H
Hypertens Res; 2023 Jul; 46(7):1738-1744. PubMed ID: 37198444
[TBL] [Abstract][Full Text] [Related]
16. Primary hyperaldosteronism decoded: a case of curable resistant hypertension.
Larsen TR; David W; Steigerwalt S; David S
Rev Cardiovasc Med; 2012; 13(4):e203-8. PubMed ID: 23470690
[TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling.
Rossi GP; Rossitto G; Amar L; Azizi M; Riester A; Reincke M; Degenhart C; Widimsky J; Naruse M; Deinum J; Schultze Kool L; Kocjan T; Negro A; Rossi E; Kline G; Tanabe A; Satoh F; Christian Rump L; Vonend O; Willenberg HS; Fuller PJ; Yang J; Chee NYN; Magill SB; Shafigullina Z; Quinkler M; Oliveras A; Dun Wu K; Wu VC; Kratka Z; Barbiero G; Battistel M; Chang CC; Vanderriele PE; Pessina AC
Hypertension; 2019 Oct; 74(4):800-808. PubMed ID: 31476901
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism.
Wachtel H; Fraker DL
Curr Cardiol Rep; 2021 Jun; 23(7):89. PubMed ID: 34081226
[TBL] [Abstract][Full Text] [Related]
19. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
20. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
